Kathleen Arcaro to Biomarkers, Tumor
This is a "connection" page, showing publications Kathleen Arcaro has written about Biomarkers, Tumor.
Connection Strength
1.772
-
Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. J Cell Physiol. 2014 Sep; 229(9):1160-9.
Score: 0.361
-
Schneider SS, Aslebagh R, Ngounou Wetie AG, Sturgeon SR, Darie CC, Arcaro KF. Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics. Adv Exp Med Biol. 2014; 806:399-408.
Score: 0.345
-
Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF. Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics. 2012 Nov; 7(11):1258-67.
Score: 0.315
-
Arcaro KF, Browne EP, Qin W, Zhang K, Anderton DL, Sauter ER. Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer. J Hum Lact. 2012 Nov; 28(4):543-6.
Score: 0.314
-
Dunphy KA, Black AL, Roberts AL, Sharma A, Li Z, Suresh S, Browne EP, Arcaro KF, Ser-Dolansky J, Bigelow C, Troester MA, Schneider SS, Makari-Judson G, Crisi GM, Jerry DJ. Inter-Individual Variation in Response to Estrogen in Human Breast Explants. J Mammary Gland Biol Neoplasia. 2020 03; 25(1):51-68.
Score: 0.132
-
Aslebagh R, Channaveerappa D, Pentecost BT, Arcaro KF, Darie CC. Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery. Adv Exp Med Biol. 2019; 1140:451-467.
Score: 0.122
-
Aslebagh R, Channaveerappa D, Arcaro KF, Darie CC. Proteomics analysis of human breast milk to assess breast cancer risk. Electrophoresis. 2018 02; 39(4):653-665.
Score: 0.114
-
Aslebagh R, Whitham D, Channaveerappa D, Lowe J, Pentecost BT, Arcaro KF, Darie CC. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk. Electrophoresis. 2023 07; 44(13-14):1097-1113.
Score: 0.041
-
Sturgeon SR, Pilsner JR, Arcaro KF, Ikuma K, Wu H, Kim SM, Chopra-Tandon N, Karpf AR, Ziegler RG, Schairer C, Balasubramanian R, Reckhow DA. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). Breast Cancer Res. 2017 Aug 18; 19(1):94.
Score: 0.028